SCHEMBL343497

SCHEMBL343497

O=C(c1ccccc1)N1c2ccccc2Sc2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
BCHE P06276 14/20 1.00
ACHE P22303 5/20 1.00
SLC6A3 Q01959 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
HPGD P15428 1/20 0.63
NOX1 Q9Y5S8 1/20 0.61
MEN1 O00255 1/20 0.60
MAPK1 P28482 1/20 0.60
KMT2A Q03164 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
P2RX4 Q99571 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27702004 0.93 BCHE (0.87) BCHEACHESLC6A3SMN1; SMN2HPGD
SCHEMBL28634368 0.90 BCHE (0.81) BCHEACHESLC6A3SMN1; SMN2HPGD
SCHEMBL29913285 0.89 BCHE (0.80) BCHEACHESLC6A3SMN1; SMN2HPGD
SCHEMBL28628271 0.86 BCHE (1.00) BCHEACHESLC6A3MEN1KMT2A
SCHEMBL28621387 0.86 BCHE (0.76) BCHEACHESLC6A3SMN1; SMN2P2RX4
SCHEMBL30137323 0.86 BCHE (1.00) BCHEACHESLC6A3SMN1; SMN2HPGD
SCHEMBL28621728 0.86 BCHE (1.00) BCHEACHESLC6A3SMN1; SMN2NOX1
SCHEMBL28624938 0.82 BCHE (0.69) BCHEACHESLC6A3SMN1; SMN2HPGD
SCHEMBL28621381 0.82 BCHE (1.00) BCHEACHEHPGD
SCHEMBL28621384 0.82 BCHE (0.70) BCHEACHESLC6A3SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12247165-B2 Anti-syneresis agents for fracturing operations HALLIBURTON ENERGY SERVICES, INC. (US) 2025-03-11 US claimed
US-20250051634-A1 ANTI-SYNERESIS AGENTS FOR FRACTURING OPERATIONS HALLIBURTON ENERGY SERVICES, INC. (US) 2025-02-13 US claimed
EP-2247687-B1 COMPOSITIONS AND METHODS OF TREATING HIGH TEMPERATURE SUBTERRANEAN FORMATIONS BAKER HUGHES A GE CO LLC (US) 2018-07-25 EP claimed
US-9902786-B2 Method for immediately terminating radical polymerizations, inhibitor solution, and use thereof ALLESSA GMBH (DE) 2018-02-27 US claimed
EP-2941443-B1 METHOD FOR IMMEDIATELY TERMINATING RADICAL POLYMERIZATIONS, INHIBITOR SOLUTION, AND USE THEREOF ALLESSA GMBH (DE) 2017-02-15 EP claimed
EP-2166060-B1 Stabilized aqueous polymer compositions TOUGAS OILFIELD SOLUTIONS GMBH (DE) 2016-08-10 EP claimed
EP-2085424-B2 Stabilized aqueous polymer compositions TOUGAS OILFIELD SOLUTIONS GMBH (DE) 2016-01-13 EP claimed
US-20150337056-A1 Method for Immediately Terminating Radical Polymerizations, Inhibitor Solution, and Use Thereof ALLESSA GMBH (DE) 2015-11-26 US claimed
US-7842741-B2 Stabilized aqueous polymer compositions ALLESSA CHEMIE GMBH (DE) 2010-11-30 US claimed
EP-2085424-B1 Stabilized aqueous polymer compositions ALLESSA CHEMIE GMBH (DE) 2010-08-25 EP claimed
US-20100075871-A1 Stabilized aqueous polymer compositions and their use TOUGAS HOLDING GMBH (DE) 2010-03-25 US claimed
EP-2166060-A1 Stabilized aqueous polymer compositions and their use Allessa Chemie GmbH (DE) 2010-03-24 EP claimed
EP-2085424-A1 Stabilized aqueous polymer compositions Allessa Chemie GmbH (DE) 2009-08-05 EP claimed
US-20090192055-A1 Stabilized aqueous polymer compositions TOUGAS HOLDING GMBH (DE) 2009-07-30 US claimed
EP-0451675-B1 Process for the direct and regioselective functionalization in position 2 of phenothiazine ZAMBON SPA (IT) 1995-11-02 EP claimed
US-5109134-A PROCESS FOR THE DIRECT AND REGIOSELECTIVE FUNCTIONALIZATION IN POSITION 2 OF PHENOTHIAZINE ZAMBON GROUP S.P.A. (IT) 1992-04-28 US claimed
US-5089613-A Sulfonation of N-acylphenothiazine with sulfuric acid, oleum or chlorosulfonic acid then reduciton to mercaptan and S-alkylation ZAMBON GROUP S.P.A. (IT) 1992-02-18 US claimed
EP-0451675-A1 Process for the direct and regioselective functionalization in position 2 of phenothiazine ZAMBON GROUP S.p.A. (IT) 1991-10-16 EP claimed
EP-0433841-A2 Process for the direct and regioselective functionalization in position 2 of phenotiazine ZAMBON GROUP S.p.A. (IT) 1991-06-26 EP claimed
JP-58038782-A None JP disclosed
US-12247165-B2 Anti-syneresis agents for fracturing operations HALLIBURTON ENERGY SERVICES, INC. (US) 2025-03-11 US disclosed
US-20250075122-A1 ADDITIVES TO PREVENT THERMAL THINNING IN POLYMER GEL SYSTEMS HALLIBURTON ENERGY SERVICES, INC. (US) 2025-03-06 US disclosed
US-20250051634-A1 ANTI-SYNERESIS AGENTS FOR FRACTURING OPERATIONS HALLIBURTON ENERGY SERVICES, INC. (US) 2025-02-13 US disclosed
CN-113149932-A Preparation method of heat-sensitive dye compound N-acyl phenothiazine 虎丘影像(苏州)有限公司 2021-07-23 CN disclosed
US-20200306258-A1 TARGETING THE TLK1/NEK1 AXIS IN PROSTATE CANCER UNITED STATES GOVERNMENT 2020-10-01 US disclosed
US-20190305228-A1 ORGANIC LIGHTEMITTING COMPOUND HAVING PHOSPHORESCENT CHARACTERISTIC AT ROOM TEMPERATURE, AND PHOSPHORESCENT ORGANIC LIGHT EMITTING DEVICE INCLUDING THE ORGANIC LIGHTEMITTING COMPOUND RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVER SITY (KR) 2019-10-03 US disclosed
EP-2247687-B1 COMPOSITIONS AND METHODS OF TREATING HIGH TEMPERATURE SUBTERRANEAN FORMATIONS BAKER HUGHES A GE CO LLC (US) 2018-07-25 EP disclosed
US-9902786-B2 Method for immediately terminating radical polymerizations, inhibitor solution, and use thereof ALLESSA GMBH (DE) 2018-02-27 US disclosed
EP-2941443-B1 METHOD FOR IMMEDIATELY TERMINATING RADICAL POLYMERIZATIONS, INHIBITOR SOLUTION, AND USE THEREOF ALLESSA GMBH (DE) 2017-02-15 EP disclosed
EP-2616473-B1 MIXTURES CONTAINING PHOSPHOROUS, PROCEDURES FOR THEIR PRODUCTION AND USE CLARIANT INT LTD (CH) 2016-11-09 EP disclosed
EP-2166060-B1 Stabilized aqueous polymer compositions TOUGAS OILFIELD SOLUTIONS GMBH (DE) 2016-08-10 EP disclosed
CN-103221416-B Containing phosphate mixture, Its Preparation Method And Use CLARIANT FINANCE (BVI) LTD. (VG) 2016-04-20 CN disclosed
EP-2085424-B2 Stabilized aqueous polymer compositions TOUGAS OILFIELD SOLUTIONS GMBH (DE) 2016-01-13 EP disclosed
US-20150337056-A1 Method for Immediately Terminating Radical Polymerizations, Inhibitor Solution, and Use Thereof ALLESSA GMBH (DE) 2015-11-26 US disclosed
EP-2941443-A1 METHOD FOR IMMEDIATELY TERMINATING RADICAL POLYMERIZATIONS, INHIBITOR SOLUTION, AND USE THEREOF Allessa GmbH (DE) 2015-11-11 EP disclosed
US-8962715-B2 Stabilized aqueous polymer compositions and their use TOUGAS OILFIELD SOLUTIONS GMBH (DE) 2015-02-24 US disclosed
WO-2014106518-A1 METHOD FOR IMMEDIATELY TERMINATING RADICAL POLYMERIZATIONS, INHIBITOR SOLUTION, AND USE THEREOF ALLESSA GMBH (DE) 2014-07-10 WO disclosed
EP-2616473-A2 PHOSPHORUS-CONTAINING MIXTURES, PROCESSES FOR PREPARING THEM AND USE THEREOF Clariant Finance (BV) Limited (VG) 2013-07-24 EP disclosed
CN-103221416-A Phosphorus-containing mixtures, processes for preparing them and use thereof CLARIANT FINANCE BVI LTD 2013-07-24 CN disclosed
US-20130172457-A1 Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2013-07-04 US disclosed
WO-2012034680-A2 PHOSPHORUS-CONTAINING MIXTURES, PROCESSES FOR PREPARING THEM AND USE THEREOF CLARIANT INTERNATIONAL LTD (CH) 2012-03-22 WO disclosed
US-20120012325-A1 HIGH TEMPERATURE STABILIZER FOR WELL TREATMENT FLUIDS AND METHODS OF USING SAME BJ SERVICES COMPANY 2012-01-19 US disclosed
US-7842741-B2 Stabilized aqueous polymer compositions ALLESSA CHEMIE GMBH (DE) 2010-11-30 US disclosed
EP-2085424-B1 Stabilized aqueous polymer compositions ALLESSA CHEMIE GMBH (DE) 2010-08-25 EP disclosed
US-20100075871-A1 Stabilized aqueous polymer compositions and their use TOUGAS HOLDING GMBH (DE) 2010-03-25 US disclosed
EP-2166060-A1 Stabilized aqueous polymer compositions and their use Allessa Chemie GmbH (DE) 2010-03-24 EP disclosed
EP-2085424-A1 Stabilized aqueous polymer compositions Allessa Chemie GmbH (DE) 2009-08-05 EP disclosed
US-20090192051-A1 HIGH TEMPERATURE STABILIZER FOR WELL TREATMENT FLUIDS AND METHODS OF USING SAME BJ SERVICES COMPANY (US) 2009-07-30 US disclosed
US-20090192055-A1 Stabilized aqueous polymer compositions TOUGAS HOLDING GMBH (DE) 2009-07-30 US disclosed
EP-0451675-B1 Process for the direct and regioselective functionalization in position 2 of phenothiazine ZAMBON SPA (IT) 1995-11-02 EP disclosed
US-5332784-A Conjugated diene, vinylaromatic copolymer ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1994-07-26 US disclosed
US-5191078-A Process for the direct and regioselective functionalization in position 2 of phenothiazine ZAMBON GROUP S.P.A. (IT) 1993-03-02 US disclosed
US-5109134-A PROCESS FOR THE DIRECT AND REGIOSELECTIVE FUNCTIONALIZATION IN POSITION 2 OF PHENOTHIAZINE ZAMBON GROUP S.P.A. (IT) 1992-04-28 US disclosed
US-5089613-A Sulfonation of N-acylphenothiazine with sulfuric acid, oleum or chlorosulfonic acid then reduciton to mercaptan and S-alkylation ZAMBON GROUP S.P.A. (IT) 1992-02-18 US disclosed
EP-0451675-A1 Process for the direct and regioselective functionalization in position 2 of phenothiazine ZAMBON GROUP S.p.A. (IT) 1991-10-16 EP disclosed
EP-0433841-A2 Process for the direct and regioselective functionalization in position 2 of phenotiazine ZAMBON GROUP S.p.A. (IT) 1991-06-26 EP disclosed
EP-0129381-B1 RECORD MATERIAL The Wiggins Teape Group Limited (GB) 1987-08-12 EP disclosed
EP-0129380-B1 RECORD MATERIAL The Wiggins Teape Group Limited (GB) 1987-08-12 EP disclosed
JP-S5838782-A ELECTROCHROMIC DISPLAY ELEMENT JAPAN ELECTRONIC IND DEV ASSOC<JEIDA> 1983-03-07 JP disclosed
JP-S5838782-A ELECTROCHROMIC DISPLAY ELEMENT JAPAN ELECTRONIC IND DEV ASSOC<JEIDA> 1983-03-07 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190305228-A1 ORGANIC LIGHTEMITTING COMPOUND HAVING PHOSPHORESCENT CHARACTERISTIC AT ROOM TEMPERATURE, AND PHOSPHORESCENT ORGANIC LIGHT EMITTING DEVICE INCLUDING THE ORGANIC LIGHTEMITTING COMPOUND MAP1LC3C, MAP1LC3A, MAP1LC3B BCHE 4076/4885ACHE 2718/4885SLC6A3 4142/4885
US-20130172457-A1 Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof C9, PHOSPHO1, C5 BCHE 2260/4885ACHE 3037/4885SLC6A3 2929/4885
US-20200306258-A1 TARGETING THE TLK1/NEK1 AXIS IN PROSTATE CANCER NEK11, NEK1, NEK10 BCHE 4051/4885ACHE 4296/4885SLC6A3 597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.